A team of doctors and scientists have successfully treated a rare genetic condition with the first-ever personalized gene-editing therapy. Results of the groundbreaking treatment have been published in The New England Journal of Medicine, with an accompanying editorial by a doctor who had previously overseen the FDA's gene-therapy regulation efforts.<br /> The patient in this historic case was KJ, an infant born with CPS1 deficiency, which has about a 50 percent mortality rate within the first week. Patients that do survive can experience severe brain disease, mental and developmental delays, and potential liver transplants. His care team developed a personalized gene-editing treatment based on CRISPR, a technology for modifying human DNA.<br /> The successful gene repair [...]
CRISPR gene-editing therapy has shown great potential to treat and even cure diseases, but scientists are now discovering how it can be used to prevent them as well. A team of researchers found a way [...]
Language models on the therapy couch: researchers at the University of Luxembourg treat ChatGPT, Gemini and Grok like patients - with disturbing consequences. The AI invents consistent trauma biograph [...]